Q32 Bio (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 29, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Company Description
- Q32 Bio is a clinical stage biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems to re-balance immunity in severe autoimmune and inflammatory diseases.
- Market
- Clinical stage therapies for autoimmune and inflammatory diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Acorn Bioventures, OrbiMed Advisors